Mitochondrial Quality Control in PMOS/PCOS: A Review of Mechanisms, Biomarkers and Therapeutic Opportunities
Polyendocrine Metabolic Ovarian Syndrome (PMOS), affecting 8-13% of reproductive-age women, is the leading cause of anovulatory infertility and carries a substantial risk of metabolic and cardiovascular morbidity. Despite therapeutic advances, fundamental pathophysiological mechanisms remain incompletely characterised....